EUVIMEDEUVIMED entdecken
Open Access

Alternative Anticoagulant Strategy to Improve the Test Sensitivity of ASTM F2888 ‐19 Standard for Platelet and Leukocyte Count Assay

Mehulkumar Patel, Carlos Serna, Anna Parrish, Arjun Gupta, Megan Jamiolkowski, Qijin Lu iD

Journal of Biomedical Materials Research Part B: Applied Biomaterials · 2024

DOI: 10.1002/jbm.b.35514 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biomedical Materials Research Part B: Applied Biomaterials, 2024. Verfasst von Mehulkumar Patel und 5 weiteren Autor:innen. Beteiligte Einrichtung: Office of Science and Engineering Laboratories, Center for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, Maryland,…. Hauptthemen laut MEDLINE: Anticoagulants. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural FDA HHS, US Food and Drug Administration, Critical Path Program of the FDA Center for Devices and Radiological Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The ASTM F2888‐19 standard for platelet and leukocyte count assay is the only standardized test method for assessing platelet and leukocyte interactions with blood‐contacting device materials. This study aimed to address two limitations of the ASTM F2888‐19 standard: low test sensitivity for leukocyte count and high test sample surface area to blood ratio (12 cm 2 /mL). Human blood from healthy adult donors was drawn into polypropylene tubes with either 3.2% sodium (Na) citrate or anticoagulant citrate dextrose solution A (ACDA). Immediately before starting the test, the blood was recalcified and heparinized to a concentration of 1, 1.5, or 2 U/mL and incubated with the test materials of varying thrombogenic potential at an exposure ratio of 6 or 12 cm 2 /mL for 1 h at 37°C ± 2°C in a shaking water bath. Complete blood count was measured using a hematology analyzer. The results show that both, Na‐citrated blood (6 or 12 cm 2 /mL exposure ratio) and ACDA blood (6 cm 2 /mL ratio), were able to differentiate thrombogenic materials from commonly used biomaterials based on platelet count changes. The magnitudes of difference between the thrombogenic materials and biomaterials depends on heparin concentration. The test sensitivity was highest when ACDA blood, heparinized to 1 U/mL heparin, was used. Moreover, the use of ACDA blood, unlike Na‐citrated blood, also allowed the assay to distinguish between the thrombogenic materials from commonly used biomaterials based on leukocyte count changes. In conclusion, the use of ACDA blood significantly increased test sensitivity of the ASTM F2888‐19 test method in differentiating materials with varying thrombogenicity based on both platelet and leukocyte counts, while reducing blood exposure ratio to 6 cm 2 /mL. These findings will be used to revise the ASTM F2888 standard in the future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnticoagulantsHumansLeukocyte CountPlatelet CountBlood PlateletsAdultMaleLeukocytesFemaleCitric Acid

Stichwörter der Autor:innen

biomaterialshemocompatibilityin vitro thrombogenicity testleukocyte countplatelet activationplatelet count

Substanzen

AnticoagulantsCitric Acid

Autor:innen und Institutionen

  • Office of Science and Engineering Laboratories, Center for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, Maryland, USA.

ORCID-Profile: Qijin Lu

Förderung

  • Intramural FDA HHS
  • US Food and Drug Administration
  • Critical Path Program of the FDA Center for Devices and Radiological Health
  • U.S. Food and Drug Administration

Zitieren

APA

Patel, M., Serna, C., Parrish, A., Gupta, A., Jamiolkowski, M., & Lu, Q. (2024). Alternative Anticoagulant Strategy to Improve the Test Sensitivity of ASTM F2888 ‐19 Standard for Platelet and Leukocyte Count Assay. Journal of Biomedical Materials Research Part B: Applied Biomaterials. https://doi.org/10.1002/jbm.b.35514

Vancouver

Patel M, Serna C, Parrish A, Gupta A, Jamiolkowski M, Lu Q. Alternative Anticoagulant Strategy to Improve the Test Sensitivity of ASTM F2888 ‐19 Standard for Platelet and Leukocyte Count Assay. Journal of Biomedical Materials Research Part B: Applied Biomaterials. 2024. doi:10.1002/jbm.b.35514

BibTeX
@article{Patel2024,
  author = {Patel, Mehulkumar and Serna, Carlos and Parrish, Anna and Gupta, Arjun and Jamiolkowski, Megan and Lu, Qijin},
  title = {Alternative Anticoagulant Strategy to Improve the Test Sensitivity of ASTM F2888 ‐19 Standard for Platelet and Leukocyte Count Assay},
  journal = {Journal of Biomedical Materials Research Part B: Applied Biomaterials},
  year = {2024},
  doi = {10.1002/jbm.b.35514}
}
Kostenlos starten →